Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIronveld Regulatory News (IRON)

Share Price Information for Ironveld (IRON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.067
Bid: 0.064
Ask: 0.07
Change: 0.002 (3.08%)
Spread: 0.006 (9.375%)
Open: 0.065
High: 0.067
Low: 0.065
Prev. Close: 0.065
IRON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Loan Facilities Agreement

3 Feb 2020 07:00

RNS Number : 6568B
Ironveld PLC
03 February 2020
 

IRONVELD PLC

("Ironveld" or the "Company")

 

Loan Facilities Agreement

Ironveld is pleased to announce that the Company has entered into definitive agreements with a consortium of high net worth investors (the "Lenders") and existing shareholders to raise, in aggregate, approximately £260,000 through short term unsecured loan facilities ("Loan Facilities"). It is intended that the proceeds from the Loan Facilities will be used for working capital purposes while the Company continues to engage with potential funders for its high purity iron powder, vanadium and titanium project in South Africa.

Highlights:

·; Total sum available under the Loan Facilities is £260,000.

 

·; The Loan will be disbursed in tranches: £110,000 by 14 February 2020 and three further monthly tranches of £50,000 at the Company's election until the full £260,000 has been lent.

 

·; Each tranche of the loan will mature six months from the date of receipt of funds by Ironveld.

 

·; The Company has issued a total of 26,000,000 warrants to subscribe for ordinary shares in the Company at a subscription price of 1p per share to the Lenders, pro rata to the amount of each loan (the "Warrants"). The Warrants have a two year life and Lenders may use outstanding balances under the Loan Facilities to exercise Warrants.

 

·; The Lenders may elect to receive any interest payments due under the Loan Facilities in ordinary shares at a price of 1p each.

 

·; Participation of Ironveld's largest shareholder and Chairman in the Loan Facilities demonstrates support.

 

The Board believes that the draw down on the Loan Facilities will provide the Company with sufficient cash resources to enable it to operate until May 2020, by which time it hopes to have secured a transaction with a strategic financing partner.

Martin Eales, Chief Executive Officer, commented:

"I have been highly encouraged by the discussions we have had so far with parties potentially interested in participating in the financing for our project. Until we are in a position to conclude this financing, the Loan Facilities announced today are extremely helpful in ensuring that our modest short-term working capital requirements are met.

"Additionally, any issue of new shares via the Warrants or in interest payments will be at a substantial 60 per cent premium to the underlying share price, thereby minimising the potential dilution for shareholders."

Terms and Conditions of the Loan Facilities

The total sum available under the Loan Facilities is £260,000. The Loan Facilities have a six month term from draw down of funds, are unsecured and carry an interest rate of eight per cent per year. The Lenders, at their sole discretion, may elect to receive the due interest in shares of Borrower with a deemed price of 1p per share, such election to be made by Lenders at least 10 business days before the Repayment Date. The interest shall accrue daily and shall be payable on the Repayment Date.

The Loan will be disbursed in tranches: £110,000 by 14 February 2020 and three further monthly tranches of £50,000 at the Company's election on the 20th of each month thereafter until the full £260,000 has been lent.

If the Company fails to make any payment due on the due date for payment, interest on the unpaid amount shall accrue daily, from the date of non-payment to the date of actual payment (both before and after judgment), at an additional five per cent.

The Company has issued a total of 26,000,000 warrants to subscribe for ordinary shares in the Company at a subscription price of 1p per share to the Lenders, pro rata to the amount of each loan (the "Warrants"). The Warrants have a two year life and Lenders may use outstanding balances under the Loan Facilities to exercise Warrants.

Should the Company carry out a capital reorganisation, subdivision or consolidation during the warrant term, the Company will redenominate the warrant strike price to reflect the pre-reorganisation terms.

Related Party Transaction

Tracarta Limited and Giles Clarke have contributed £50,000 and £10,000 respectively to the Loan Facilities and been issued with 5,000,000 and 1,000,000 Warrants respectively. Tracarta Limited holds 12.27 per cent of the issued share capital in the Company, and Giles Clarke is the Company's Chairman. Therefore both are related parties for the purposes of the AIM Rules for Companies. Accordingly, the participation of the Related Parties in the Loan Facilities constitutes a related party transaction pursuant to Rule 13 of the AIM Rules for Companies.

The independent directors of Ironveld, being all those except Giles Clarke, having consulted with the Company's Nominated Adviser finnCap, consider that the terms of the Loan Facilities are fair and reasonable insofar as the Company's shareholders are concerned.

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

For further information, please contact:

Ironveld plc

Giles Clarke, Chairman

Martin Eales, Chief Executive Officer

 

 

c/o Blytheweigh

+44 20 7138 3204

 

finnCap (Nomad and Broker)

Christopher Raggett / Hannah Boros

 

 

+44 20 7220 0500

Blytheweigh

Tim Blythe / Megan Ray

 

+44 20 7138 3204

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRUPUGGPUPUGUP
Date   Source Headline
2nd May 20247:00 amRNSAppointment of CEO
24th Apr 20247:00 amRNSWorking Capital Facility
23rd Apr 20247:00 amRNSBlocklisting Return
2nd Apr 20245:30 pmRNSTR-1: Notification of major holdings
28th Mar 20247:00 amRNSInterim results for the 6 months ended 31 Dec 2023
29th Feb 202411:36 amRNSTR-1: Notification of major holdings
23rd Feb 20247:00 amRNSTR-1: Notification of major holdings
23rd Feb 20247:00 amRNSReceipt of Non-Binding Term Sheet and Board Change
7th Feb 20243:20 pmRNSTR-1: Notification of major holdings
2nd Feb 20241:48 pmRNSWorking Capital Facility
10th Jan 202410:45 amRNSResult of Annual General Meeting
22nd Dec 20237:00 amRNSNotice of AGM
20th Dec 20237:00 amRNSFinal Results for the year ended 30 June 2023
14th Nov 20231:40 pmRNSTR-1: Notification of major holdings
13th Nov 20232:10 pmRNSResult of General Meeting and Total Voting Rights
8th Nov 202311:50 amRNSTR-1: Notification of major holdings
7th Nov 20234:45 pmRNSTR-1: Notification of major holdings
27th Oct 20234:07 pmRNSPosting of Circular and Notice of General Meeting
26th Oct 20237:00 amRNSFundraising at a premium and Board change
23rd Oct 20237:00 amRNSBlocklisting Return
18th Sep 20237:00 amRNSOperations Update
1st Sep 20237:00 amRNSUpdate on DMS Magnetite Joint Venture
21st Jul 20232:45 pmRNSTR-1: Notification of major holdings
14th Jul 20231:06 pmRNSDirector’s Dealing
13th Jul 20232:08 pmRNSDirector’s Dealing
12th Jul 20232:50 pmRNSTR-1: Notification of major holdings
4th Jul 20238:05 amRNSTR-1: Notification of major holdings
28th Jun 20237:00 amRNSFirst Sales Achieved
27th Jun 202311:56 amRNSTR-1: Notification of major holdings
6th Jun 202310:54 amRNSIssue of Equity
5th Jun 20237:00 amRNSBoard Appointment
17th May 20232:13 pmRNSWebinar Presentation
12th May 20237:00 amRNSOperations Update
24th Apr 20237:00 amRNSBlocklisting Return
4th Apr 202312:20 pmRNSDirector Dealings
3rd Apr 20237:00 amRNSLOI signed with BurnStar Technologies
30th Mar 20237:00 amRNSInterim results for the 6 months ended 31 Dec 2022
29th Mar 202310:00 amRNSAcquisition Unconditional
15th Mar 20234:32 pmRNSTR-1: Notification of major holdings
15th Mar 202311:13 amRNSTR-1: Notification of major holdings
15th Mar 202310:58 amRNSTotal Voting Rights
13th Mar 202311:15 amRNSResult of General Meeting
2nd Mar 202311:56 amRNSTR-1: Notification of major holdings
2nd Mar 202310:15 amRNSTR-1: Notification of major holdings
1st Mar 20235:36 pmRNSDirector Dealing
1st Mar 20234:56 pmRNSTR-1: Notification of major holdings
28th Feb 20234:15 pmRNSGrant of Share Options
24th Feb 20234:00 pmRNSPosting of GM Circular
24th Feb 20231:25 pmRNSTR-1: Notification of major holdings
23rd Feb 202311:00 amRNSPlacing to raise £2.0 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.